UBS Group’s Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant BITE.U Stock Holding History

UBS Group’s Portfolio BITE.U Stock Details BITE.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,243	Closed	-$32K	–	11333
2022 Q3	$32K	Buy	3,243 +282	+10%	+$2.78K	﹤0.01%	6809
2022 Q2	$29K	Buy	2,961 +1,304	+79%	+$12.9K	﹤0.01%	6450
2022 Q1	$16K	Buy	1,657 +419	+34%	+$4.16K	﹤0.01%	7768
2021 Q4	$12K	Buy	1,238 +3	+0.2%	+$30	﹤0.01%	8594
2021 Q3	$12K	Sell	1,235 -3,777	-75%	-$37.7K	﹤0.01%	7804
2021 Q2	$50K	Buy	5,012 +2,595	+107%	+$25.9K	﹤0.01%	6436
2021 Q1	$24K	Buy	+2,417	New	+$24.3K	﹤0.01%	7216

Other funds holding BITE.U

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

SFM

Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

UBS Group's BITE.U Position: Q4 2022 in Review

UBS Group sold out of Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant (BITE.U) in Q4 2022, closing a stake of 3,243 shares — an estimated $32K sold.

UBS Group first reported a position in BITE.U in Q1 2021 and held it in 7 quarters. The position peaked at $50K in Q2 2021. 4 funds tracked by Wall St. Rank hold BITE.U as of Q4 2022.

UBS Group reported no remaining Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant position as of Q4 2022 after selling out during the quarter.
UBS Group sold 3,243 Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant shares in Q4 2022, an estimated $32K.
UBS Group first reported a position in Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant in Q1 2021 and held it in 7 quarters.
UBS Group's Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant position peaked at $50K in Q2 2021.
4 funds tracked by Wall St. Rank held Bite Acquisition Corp. Units, each consisting of one share of common stock, and one-half of one redeemable warrant as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.